TY  - GEN
AU  - Fatodu,Hugh
TI  - Evolving regulatory landscape with erythropoiesis-stimulating agents and impact on managed care
SN  - 1936-2692
PY  - 2010///0629
KW  - Anemia
KW  - drug therapy
KW  - Cardiovascular Diseases
KW  - chemically induced
KW  - Drug and Narcotic Control
KW  - Drug-Related Side Effects and Adverse Reactions
KW  - Hematinics
KW  - adverse effects
KW  - Humans
KW  - Insurance, Health, Reimbursement
KW  - Kidney Failure, Chronic
KW  - complications
KW  - Managed Care Programs
KW  - Neoplasms
KW  - Product Surveillance, Postmarketing
KW  - Risk Assessment
KW  - Stroke
KW  - United States
KW  - epidemiology
KW  - United States Food and Drug Administration
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
ER  -